Biotech · Private company
H3 Biomedicine Inc.
Track this companyFree. Adds H3 Biomedicine Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- H3B-6527Phase 1 · Advanced Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101PHASE1 · TERMINATED · started Feb 24, 2020ClinicalTrials.gov NCT04144140 · fetched Nov 12, 2026
- A Study of Stimulator of Interferon Genes (STING) Agonist E7766 in Non-muscle Invasive Bladder Cancer (NMIBC) Including Participants Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy, INPUT-102PHASE1 · WITHDRAWN · started Feb 13, 2020ClinicalTrials.gov NCT04109092 · fetched Nov 12, 2026
- Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular CarcinomaPHASE1 · COMPLETED · started Dec 28, 2016ClinicalTrials.gov NCT02834780 · fetched Nov 12, 2026